PEACH

Procalcitonin: Evaluation of Antibiotic use in COVID-19 Hospitalised patients. @UniversityLeeds and @CTRCardiffUni

[PEACH @PEACH_Study1]

Latest publication from ⁦@PEACH_Study1⁩

Cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study | Journal of Antimicrobial Chemotherapy | Oxford Academic https://t.co/ZIuJLJCI9j

[Dr Joanne Euden @Dr_JoanneEuden]

Delighted that the final study synopsis for @PEACH_Study1 has now been published in @NIHRresearch library! Full report and results in the 'related links' here: https://t.co/pj9xKMft8J

@CTRCardiffUni @CarrolEnitan @j_sandoe @UniversityLeeds

[PEACH @PEACH_Study1]

💥💥💥MAIN RESULTS💥💥💥

The PEACH team are delighted to finally share the main results of this study!
@CarrolEnitan @j_sandoe @emma_tj1 @Dr_JoanneEuden @LBrookesHowell @DetelinaGrozeva @CTRCardiffUni @UniversityLeeds and many others.

https://t.co/g9PWSEXieF

[NHS NE&Yorks AMR - Philip HOWARD OBE @AntibioticLeeds]

Great to share our work on @PEACH_Study1 on #procalcitonin shortening antibiotic course length during #Covid #ECCMID2024 or #ESCMIDGlobal

[NHS NE&Yorks AMR - Philip HOWARD OBE @AntibioticLeeds]

@PEACH_Study1 is an excellent example of using diagnostics to reduce inappropriate antibiotics use during a viral pandemic outbreak @glgamr #eccmid2024 #escmidglobal

[PEACH @PEACH_Study1]

@gpollara @ESCMID @emma_tj1 @j_sandoe It is!

[PEACH @PEACH_Study1]

And we are here @ESCMID about to go to a sepsis talk by Mervyn Singer and then present the results of our @PEACH_Study1.

[PEACH @PEACH_Study1]

@gpollara @YouTube @NIHRresearch @j_sandoe @CarrolEnitan @CTRCardiffUni @UniversityLeeds Thanks. In review so hopefully soon!

[PEACH @PEACH_Study1]

💥RESULTS 💥

We are delighted to finally share the results of our PEACH study.

Did procalcitonin tests affect antibiotic prescribing for early COVID-19... https://t.co/0wz2zGiQ4f via @YouTube

@NIHRresearch @j_sandoe @CarrolEnitan @CTRCardiffUni @UniversityLeeds #AMS #AMR

[PEACH @PEACH_Study1]

We’re looking forward to presenting results of the @PEACH_Study1 at @ECCMID in Barcelona next month. Thank you to everyone who was involved.

@j_sandoe @CarrolEnitan @emma_tj1 @Dr_JoanneEuden @DetelinaGrozeva @WMaboshe @LBrookesHowell Josie Henley, Phil Pallmann & many more!

[PEACH @PEACH_Study1]

First published findings from @PEACH_Study1 qualitative work stream today in @BMJ_Open.

https://t.co/wTEt1rZZMl

@josie_henley @LBrookesHowell @Dr_JoanneEuden @j_sandoe @emma_tj1 @CarrolEnitan @CTRCardiffUni @UniversityLeeds @NIHRresearch

[Dr Joanne Euden @Dr_JoanneEuden]

It’s the end of #WAAW2023 & we’ve been highlighting work from our infections division at @CTRCardiffUni. #AMR & antimicrobial stewardship needs to be at forefront of our minds. We need better diagnostics, implemented quickly once evidence exists for better patient outcomes.

[CTRCardiffUni @CTRCardiffUni]

Tackling AMR Together 🤝💊

Collaboration is key in fighting AMR. Discover the united efforts in our #WAAW2023 blog.

🔗https://t.co/Ui4ACKWdjv

@ResearchWales @CUBLSResearch @UKCTUNetwork @TreialonCymru @kerryhood @DPMRes @Pronto_Trial @PEACH_Study1 @BATCH_trial @CarrolEnitan

[PEACH @PEACH_Study1]

We have just about finished analysis for @PEACH_Study1 (Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients). Make sure you follow for updates, results and dissemination activities. #WAAW2023

@CarrolEnitan @j_sandoe @NIHRresearch @UniversityLeeds

[PEACH @PEACH_Study1]

As well as our @PEACH_Study1, see what other studies @CTRCardiffUni are conducting on diagnosis of infections.

Antimicrobial resistance is an urgent global threat. It is vital that we #KeepAntibioticsWorking

@j_sandoe @CarrolEnitan

[CTRCardiffUni @CTRCardiffUni]

🌍💊This #WAAW2023, learn how @CTRCardiffUni is contributing to research on antimicrobial resistance (AMR).

Our World Antimicrobial Resistance Awareness Week blog:

🔗https://t.co/Ui4ACKVFtX

@ResearchWales @UKCTUNetwork @Pronto_Trial @PEACH_Study1 @BATCH_trial @CarrolEnitan

[PEACH @PEACH_Study1]

Alot of work ongoing in the background to get manuscripts submitted. We have an incredibly rich repository of clinical data which reflects the huge effort from all our participating Trusts. We look forward to sharing the results of this study with you over the next few months.

[PEACH @PEACH_Study1]

We have finished all analysis. We hope to have main results of @PEACH_Study1 published very soon alongside our qualitative and health economics papers.

https://t.co/xS81FzZCVN

@j_sandoe @CarrolEnitan @AntibioticLeeds @MartinLlewelyn @LBrookesHowell @emma_tj1 @Dr_JoanneEuden

[PEACH @PEACH_Study1]

Thank you to all our sites for participating in the close down process. All sites are now closed.

Analysis of data is almost complete and we look forward to sharing the results in due course.

[PEACH @PEACH_Study1]

Looking forward to presenting the results of our study at an internal @CTRCardiffUni meeting this week with @CarrolEnitan, and with our wider investigator group next month. Thank you again to all site staff who worked so hard to gather patient data for this study. #ICTD2023

[Dr Joanne Euden @Dr_JoanneEuden]

Tomorrow is #ICTD2023 and a great way to roll into next week when we discuss results of @PEACH_Study1, @BATCH_trial, @PRECISE_study and finalise plans for our first PROTECT stakeholder meeting in Leeds with @CarrolEnitan and @CTRCardiffUni colleagues.